The changes of MRP2 expression in three kinds of pulmonary inflammation models: the downregulation occurred in cigarette smoke extract (CSE) stimulation group and CSE plus LPS stimulation group, unchanged in LPS stimulation group

References

• Borst P, Elferink RO. 2002. Mammalian ABC transporters in health and disease. Annu Rev Biochem. 71:537–592.
   PubMed Web of Science ®Google Scholar
• Borst P, Evers R, Kool M, Wijnholds J. 2000. A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst. 92(16):1295–1302.
   PubMed Web of Science ®Google Scholar
• Chen B, You WJ, Xue S, Qin H, Zhao XJ, Zhang M, Liu XQ, Zhu SY, Jiang HD. 2016. Overexpression of farnesoid X receptor in small airways contributes to epithelial to mesenchymal transition and COX-2 expression in chronic obstructive pulmonary disease. J Thorac Dis. 8(11):3063–3074.
   PubMed Web of Science ®Google Scholar
• Corlăţeanu A, Odajiu I, Botnaru V, Cemirtan S. 2016. From smoking to COPD–current approaches. Pneumologia (Bucharest, Romania). 65(1):20–23.
   PubMedGoogle Scholar
• Dean M, Rzhetsky A, Allikmets R. 2001. The human ATP-binding cassette (ABC) transporter superfamily. Genome Res. 11(7):1156–1166.
   PubMed Web of Science ®Google Scholar
• Endter S, Francombe D, Ehrhardt C, Gumbleton M. 2009. RT-PCR analysis of ABC, SLC and SLCO drug transporters in human lung epithelial cell models. J Pharm Pharmacol. 61(5):583–591.
   PubMed Web of Science ®Google Scholar
• Fei S, Cao L, Pan L. 2018. microRNA‑3941 targets IGF2 to control LPS‑induced acute pneumonia in A549 cells. Mol Med Rep. 17(3):4019–4026.
   PubMed Web of Science ®Google Scholar
• Fletcher C, Peto R. 1977. The natural history of chronic airflow obstruction. Br Med J. 1(6077):1645–1648.
   PubMed Web of Science ®Google Scholar
• Gerk PM, Vore M. 2002. Regulation of expression of the multidrug resistance-associated protein 2 (MRP2) and its role in drug disposition. J Pharmacol Exp Ther. 302(2):407–415.
   PubMed Web of Science ®Google Scholar
• Haghi M, Ong HX, Traini D, Young P. 2014. Across the pulmonary epithelial barrier: Integration of physicochemical properties and human cell models to study pulmonary drug formulations. Pharmacol Ther. 144(3):235–252.
   PubMed Web of Science ®Google Scholar
• Hardaker EL, Freeman MS, Dale N, Bahra P, Raza F, Banner KH, Poll C. 2010. Exposing rodents to a combination of tobacco smoke and lipopolysaccharide results in an exaggerated inflammatory response in the lung. Br J Pharmacol. 160(8):1985–1996.
   PubMed Web of Science ®Google Scholar
• He Y, Jiang B, Li LS, Li LS, Ko L, Wu L, Sun DL, He SF, Liang BQ, Hu FB, et al. 2012. Secondhand smoke exposure predicted COPD and other tobacco-related mortality in a 17-year cohort study in China. Chest. 142(4):909–918.
   PubMed Web of Science ®Google Scholar
• Hecht SS. 1999. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst. 91(14):1194–1210.
   PubMedGoogle Scholar
• Homolya L, Váradi A, Sarkadi B. 2003. Multidrug resistance-associated proteins: Export pumps for conjugates with glutathione, glucuronate or sulfate. BioFactors (Oxford, England). 17(1-4):103–114.
   PubMed Web of Science ®Google Scholar
• Jemnitz K, Heredi-Szabo K, Janossy J, Ioja E, Vereczkey L, Krajcsi P. 2010. ABCC2/Abcc2: a multispecific transporter with dominant excretory functions. Drug Metab Rev. 42(3):402–436.
   PubMed Web of Science ®Google Scholar
• Jiménez-Ruiz CA, Andreas S, Lewis KE, Tonnesen P, van Schayck CP, Hajek P, Tonstad S, Dautzenberg B, Fletcher M, Masefield S, et al. 2015. Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit. Eur Respir J. 46(1):61–79.
   PubMed Web of Science ®Google Scholar
• Keppler D. 2014. The roles of MRP2, MRP3, OATP1B1, and OATP1B3 in conjugated hyperbilirubinemia. Drug Metab Dispos. 42(4):561–565.
   PubMed Web of Science ®Google Scholar
• Keppler D, König J. 2000. Hepatic secretion of conjugated drugs and endogenous substances. Semin Liver Dis. 20(3):265–272.
   PubMed Web of Science ®Google Scholar
• Kruh GD, Belinsky MG. 2003. The MRP family of drug efflux pumps. Oncogene. 22(47):7537–7552.
   PubMed Web of Science ®Google Scholar
• Lee SY, Kang EJ, Hur GY, Jung KH, Jung HC, Lee SY, Kim JH, Shin C, In KH, Kang KH, et al. 2006. The inhibitory effects of rebamipide on cigarette smoke-induced airway mucin production. Respiratory Medicine. 100(3):503–511.
   PubMed Web of Science ®Google Scholar
• Leslie EM, Ghibellini G, Nezasa K, Brouwer KL. 2007. Biotransformation and transport of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in bile duct-cannulated wild-type and Mrp2/Abcc2-deficient (TR) Wistar rats. Carcinogenesis. 28(12):2650–2656.
   PubMed Web of Science ®Google Scholar
• Leslie EM, Ito K, Upadhyaya P, Hecht SS, Deeley RG, Cole SP. 2001. Transport of the beta -O-glucuronide conjugate of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the multidrug resistance protein 1 (MRP1). Requirement for glutathione or a non-sulfur-containing analog. J Biol Chem. 276(30):27846–27854.
   PubMed Web of Science ®Google Scholar
• Li C, Schuetz JD, Naren AP. 2010. Tobacco carcinogen NNK transporter MRP2 regulates CFTR function in lung epithelia: implications for lung cancer. Cancer Lett. 292(2):246–253.
   PubMed Web of Science ®Google Scholar
• Li D, Qi C, Zhou J, Wen Z, Zhu X, Xia H, Song J. 2020. LPS-induced inflammation delays the transportation of ASP + due to down-regulation of OCTN1/2 in alveolar epithelial cells. J Drug Target. 28(4):437–447.
   PubMed Web of Science ®Google Scholar
• Liang S, Meng X, Wang Z, Liu J, Kuang H, Wang Q. 2018. Polysaccharide from Ephedra sinica Stapf inhibits inflammation expression by regulating Factor-β1/Smad2 signaling. Int J Biol Macromol. 106:947–954.
   PubMed Web of Science ®Google Scholar
• Liu Q, Yang H, Xu S, Sun X. 2018. Downregulation of p300 alleviates LPS-induced inflammatory injuries through regulation of RhoA/ROCK/NF-κB pathways in A549 cells. Biomed Pharmacother. 97:369–374.
   PubMed Web of Science ®Google Scholar
• Marrone J, Tocchetti GN, Danielli M, Mottino AD, Marinelli RA. 2019. Improved hepatic MRP2/ABCC2 transport activity in LPS-induced cholestasis by aquaporin-1 gene transfer. Biochimie. 165:179–182.
   PubMed Web of Science ®Google Scholar
• Nakamura S, Yanagihara K, Araki N, Yamada K, Morinaga Y, Izumikawa K, Seki M, Kakeya H, Yamamoto Y, Kamihira S, et al. 2011. High-dose tobramycin inhibits lipopolysaccharide-induced MUC5AC production in human lung epithelial cells. Eur J Pharmacol. 659(1):67–71.
   PubMed Web of Science ®Google Scholar
• Nie YC, Wu H, Li PB, Luo YL, Zhang CC, Shen JG, Su WW. 2012. Characteristic comparison of three rat models induced by cigarette smoke or combined with LPS: to establish a suitable model for study of airway mucus hypersecretion in chronic obstructive pulmonary disease. Pulm Pharmacol Ther. 25(5):349–356.
   PubMed Web of Science ®Google Scholar
• Nies AT, Keppler D. 2007. The apical conjugate efflux pump ABCC2 (MRP2). Pflugers Arch. 453(5):643–659.
   PubMed Web of Science ®Google Scholar
• Oswald NC, Medvei VC. 1955. Chronic bronchitis; the effect of cigarette-smoking. Lancet (London, England). 269(6895):843–844.
   PubMedGoogle Scholar
• Peng Z, Zhang W, Qiao J, He B. 2018. Melatonin attenuates airway inflammation via SIRT1 dependent inhibition of NLRP3 inflammasome and IL-1β in rats with COPD. Int Immunopharmacol. 62:23–28.
   PubMed Web of Science ®Google Scholar
• Qi C, Zhou J, Wang Z, Fang X, Li D, Jin Y, Song J. 2020. Cigarette smoke extract combined with lipopolysaccharide reduces OCTN1/2 expression in human alveolar epithelial cells in vitro and rat lung in vivo under inflammatory conditions. Int Immunopharmacol. 87:106812.
   PubMed Web of Science ®Google Scholar
• Salvi S. 2014. Tobacco smoking and environmental risk factors for chronic obstructive pulmonary disease. Clin Chest Med. 35(1):17–27.
   PubMed Web of Science ®Google Scholar
• Smirnova MG, Guo L, Birchall JP, Pearson JP. 2003. LPS up-regulates mucin and cytokine mRNA expression and stimulates mucin and cytokine secretion in goblet cells. Cell Immunol. 221(1):42–49.
   PubMed Web of Science ®Google Scholar
• Stevenson CS, Birrell MA. 2011. Moving towards a new generation of animal models for asthma and COPD with improved clinical relevance. Pharmacol Ther. 130(2):93–105.
   PubMed Web of Science ®Google Scholar
• Wang X, Wang Y, Zhao X, Andersson R, Song Z, Yang D. 2009. Potential effects of peroxisome proliferator-activated receptor activator on LPS-induced lung injury in rats. Pulm Pharmacol Ther. 22(4):318–325.
   PubMed Web of Science ®Google Scholar
• Zheng H, Liu Y, Huang T, Fang Z, Li G, He S. 2009. Development and characterization of a rat model of chronic obstructive pulmonary disease (COPD) induced by sidestream cigarette smoke. Toxicol Lett. 189(3):225–234.
   PubMed Web of Science ®Google Scholar
• Zhou J, Qi C, Fang X, Wang Z, Zhang S, Li D, Song J. 2021. DJ-1 modulates Nrf2-mediated MRP1 expression by activating Wnt3a/β-catenin signalling in A549 cells exposed to cigarette smoke extract and LPS. Life Sci. 119089. Advance online publication.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Tan X, Kuang W, Liu L, Wan L. 2012. Erythromycin ameliorates cigarette-smoke-induced emphysema and inflammation in rats. Translat Res. 159(6):464–472.
   PubMed Web of Science ®Google Scholar